Welcome to the 25th case of the Skeleton Key Group, a team of 50-odd nephrology fellows who work together to build a monthly education package for the Renal Fellow Network. These are actual cases (without patient identifying information)…
The use of SGLT2 inhibitors in patients with kidney disease is becoming the standard of care. This table covers many of the common potential side effects from several of the major clinical trials. Red- difference showing more adverse…
The incidence of acute brain injury, both ischemic and hemorrhagic stroke, is increasing in patients with end-stage kidney disease (ESKD). Risk factors include older age and co-morbidities requiring long-term systemic anticoagulation. Patients with acute traumatic brain injury develop…
